Acquiring a majority stake in Green Innovation, EW Nutrition has expanded its technology capabilities and gut health portfolio. The new deal gives the company majority ownership of innovative brands such as Argat or Oxilem.
A global provider of animal nutrition solutions, EW Nutrition has announced the acquisition of a majority stake in Austrian company Green Innovation, producer and patent-holder of several in-feed solutions in the gut health space.
Green Innovation, based in Innsbruck, and EW Nutrition, headquartered in Northern Germany, have signed the agreement on Thursday, 20 March, 2025. “By acquiring 52% of our company, EW Nutrition implicitly recognizes the strength of our solutions, know-how, and technologies. We are happy that we found such a solid and dynamic partner, and we are excited to work together for the next level of animal gut health,” said Alexander Herbst, CEO of Green Innovation.
For EW Nutrition, solutions such as Ventar D, Pretect D, Activo or Activo Liquid have already carved an important space in the gut health arena. “With the addition of Green Innovation’s solutions, we see a great opportunity to complete our gut health portfolio and to position ourselves for the future. Challenges are evolving and so our solutions must evolve as well,” noted CEO of EW Nutrition, Jan Vanbrabant.
With the fourth acquisition in the last five years, EW Nutrition shows its continued drive toward further development and expansion, according to a statement. The new deal gives the company majority ownership of innovative brands such as Argat or Oxilem, as well as patents, know-how, and a number of team members who will manage the transfer together with their legacy counterparts.
Green Innovation customers will be supported to the usual high standards, while the assets, brands, and go-to-market will be transitioned to EW Nutrition in the coming period, the companies explained.
